|
|
||||||||
and MAP kinase in bradykinin-induced
arachidonic acid release in rabbit CCD cells
1 Departments of Cellular and Molecular Medicine, 2 Biochemistry, and 3 Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada K1H 8M5
Arachidonic acid
(AA) release is the rate-limiting step in the production of
prostaglandins, an important class of autocrine/paracrine factors that
modulate collecting duct function. Previous results from this
laboratory have established cytosolic phospholipase A2
(cPLA2) as the enzyme
responsible for bradykinin (BK)-stimulated AA mobilization in rabbit
cortical collecting duct (RCCD) cells, and the present study pursues
the intracellular signaling mechanisms responsible for its activation.
Pretreatment of cells with Ro-31-8220, an inhibitor of protein kinase C
(PKC), or PD-98059, an inhibitor of the mitogen-activated protein
kinase (MAPK) cascade, resulted in a 50-60% reduction in
BK-stimulated AA release. Incubation of RCCD cells with a combination
of both Ro-31-8220 and PD-98059 did not achieve a greater inhibition of
either BK-stimulated AA release or
cPLA2 activity, possibly
indicating that MAPK activation was dependent upon prior activation of
PKC. This was supported by the observation that BK-induced MAPK
activation could be reversed by either inhibitor. Additional
experiments dealing with immunoblots for PKC isozymes revealed that
RCCD cells express PKC species
,
,
, and
. Following BK
stimulation, only PKC
translocated to the particulate fraction.
Based on these results, it appears that PKC is activated and involved
in the sequential activation of MAPK and
cPLA2 following BK treatment. The
results also suggest that PKC
may be the isozyme implicated in the
process.
cytosolic phospholipase A2; mitogen-activated protein kinase; protein kinase C isozymes
This article has been cited by other articles:
![]() |
Y. V. Mukhin, E. A. Garnovsky, M. E. Ullian, and M. N. Garnovskaya Bradykinin B2 Receptor Activates Extracellular Signal-Regulated Protein Kinase in mIMCD-3 Cells via Epidermal Growth Factor Receptor Transactivation J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 968 - 977. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nowicki, M. S. Kruse, H. Brismar, and A. Aperia Dopamine-induced translocation of protein kinase C isoforms visualized in renal epithelial cells Am J Physiol Cell Physiol, December 1, 2000; 279(6): C1812 - C1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Tian, Z. Zhang, and D. M. Cohen MAPK signaling and the kidney Am J Physiol Renal Physiol, October 1, 2000; 279(4): F593 - F604. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Parfenova, V. Massie, and C. W. Leffler Developmental changes in endothelium-derived vasorelaxant factors in cerebral circulation Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H780 - H788. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Laporte, P. E. Moore, J. H. Abraham, G. N. Maksym, B. Fabry, R. A. Panettieri Jr., and S. A. Shore Role of ERK MAP kinases in responses of cultured human airway smooth muscle cells to IL-1beta Am J Physiol Lung Cell Mol Physiol, November 1, 1999; 277(5): L943 - L951. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Cussac, S. Schaak, C. Gales, C. Flordellis, C. Denis, and H. Paris alpha 2B-Adrenergic receptors activate MAPK and modulate proliferation of primary cultured proximal tubule cells Am J Physiol Renal Physiol, May 1, 2002; 282(5): F943 - F952. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |